Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17:473–86. doi:https://doi.org/10.1038/s41575-020-0286-8.
Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5:908–17. doi:https://doi.org/10.1016/S2468-1253(20)30217-X.
Mearin F, Lacy BE, Chang L, Chey WD, Lembo AJ, Simren M, et al. Bowel Disorders Gastroenterology. 2016;150:1393–407. doi:https://doi.org/10.1053/j.gastro.2016.02.031.
Akehurst RL, Brazier JE, Mathers N, O’Keefe C, Kaltenthaler E, Morgan A, et al. Health-related quality of life and cost impact of irritable bowel syndrome in a UK primary care setting. PharmacoEconomics. 2002;20:455–62. doi:https://doi.org/10.2165/00019053-200220070-00003.
Frändemark Å, Törnblom H, Jakobsson S, Simrén M. Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem. Am J Gastroenterol. 2018;113:1540–9. doi:https://doi.org/10.1038/s41395-018-0262-x.
CAS Article PubMed Google Scholar
Simrén M, Tack J. New treatments and therapeutic targets for IBS and other functional bowel disorders. Nat Rev Gastroenterol Hepatol. 2018;15:589–605. doi:https://doi.org/10.1038/s41575-018-0034-5.
CAS Article PubMed Google Scholar
Camilleri M. Management Options for Irritable Bowel Syndrome. Mayo Clin Proc. 2018;93:1858–1872. doi: https://doi.org/10.1016/j.mayocp.2018.04.032.
Camilleri M, Shin A, Busciglio I, Carlson P, Acosta A, Bharucha AE, et al. Validating biomarkers of treatable mechanisms in irritable bowel syndrome. Neurogastroenterol Motil. 2014;26:1677–85. doi:https://doi.org/10.1111/nmo.12421.
CAS Article PubMed PubMed Central Google Scholar
Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, et al. Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions. Endocr Rev. 2019;40:1109–51. doi:https://doi.org/10.1210/er.2018-00126.
Liu X, Baylin A, Levy PD. Vitamin D deficiency and insufficiency among US adults: prevalence, predictors and clinical implications. Br J Nutr. 2018;119:928–36. doi:https://doi.org/10.1017/S0007114518000491.
CAS Article PubMed Google Scholar
Mogire RM, Mutua A, Kimita W, Kamau A, Bejon P, Pettifor JM, et al. Prevalence of vitamin D deficiency in Africa: a systematic review and meta-analysis. Lancet Glob Health. 2020;8:e134–42. doi:https://doi.org/10.1016/S2214-109X(19)30457-7.
Nwosu BU, Maranda L, Candela N. Vitamin D status in pediatric irritable bowel syndrome. PLoS ONE. 2017;12:e0172183. doi:https://doi.org/10.1371/journal.pone.0172183.
CAS Article PubMed PubMed Central Google Scholar
Barbalho SM, Goulart RA, Araújo AC, Guiguer ÉL, Bechara MD. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Rev Gastroenterol Hepatol. 2019;13:345–59. doi:https://doi.org/10.1080/17474124.2019.1570137.
CAS Article PubMed Google Scholar
Casseb GAS, Kaster MP, Rodrigues ALS. Potential Role of Vitamin D for the Management of Depression and Anxiety. CNS Drugs. 2019;33:619–37. doi:https://doi.org/10.1007/s40263-019-00640-4.
CAS Article PubMed Google Scholar
Jamilian H, Amirani E, Milajerdi A, Kolahdooz F, Mirzaei H, Zaroudi M, et al. The effects of vitamin D supplementation on mental health, and biomarkers of inflammation and oxidative stress in patients with psychiatric disorders: A systematic review and meta-analysis of randomized controlled trials. Prog Neuropsychopharmacol Biol Psychiatry. 2019;94:109651. doi:https://doi.org/10.1016/j.pnpbp.2019.109651.
CAS Article PubMed Google Scholar
Filgueiras MS, Rocha NP, Novaes JF, Bressan J. Vitamin D status, oxidative stress, and inflammation in children and adolescents: A systematic review. Crit Rev Food Sci Nutr. 2020;60:660–9. doi:https://doi.org/10.1080/10408398.2018.1546671.
CAS Article PubMed Google Scholar
Holtmann GJ, Ford AC, Talley NJ. Pathophysiology of irritable bowel syndrome. Lancet Gastroenterol Hepatol. 2016;1:133–46. doi:https://doi.org/10.1016/S2468-1253(16)30023-1.
Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402. doi:https://doi.org/10.1046/j.1365-2036.1997.142318000.x.
CAS Article PubMed Google Scholar
Patrick DL, Drossman DA, Frederick IO, DiCesare J, Puder KL. Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig Dis Sci. 1998;43:400–11. doi:https://doi.org/10.1023/a:1018831127942.
CAS Article PubMed Google Scholar
Drossman D, Morris CB, Hu Y, Toner BB, Diamant N, Whitehead WE, et al. Characterization of health related quality of life (HRQOL) for patients with functional bowel disorder (FBD) and its response to treatment. Am J Gastroenterol. 2007;102:1442–53. doi:https://doi.org/10.1111/j.1572-0241.2007.01283.x.
Higgins JPT, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928. doi:https://doi.org/10.1136/bmj.d5928.
Article PubMed PubMed Central Google Scholar
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. J Clin Epidemiol. 2011;64:383–94. doi:https://doi.org/10.1016/j.jclinepi.2010.04.026.
Abbasnezhad A, Amani R, Hajiani E, Alavinejad P, Cheraghian B, Ghadiri A. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol Motil. 2016;28:1533–44. doi:https://doi.org/10.1111/nmo.12851.
CAS Article PubMed Google Scholar
Khalighi Sikaroudi M, Mokhtare M, Janani L, Faghihi Kashani AH, Masoodi M, Agah S, et al. Vitamin D3 Supplementation in Diarrhea-Predominant Irritable Bowel Syndrome Patients: The Effects on Symptoms Improvement, Serum Corticotropin-Releasing Hormone, and Interleukin-6 - A Randomized Clinical Trial. Complement Med Res. 2020;27:302–9. doi:https://doi.org/10.1159/000506149.
El Amrousy D, Hassan S, El Ashry H, Yousef M, Hodeib H. Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful? A randomized controlled trial. Saudi J Gastroenterol. 2018;24:109–14. doi:https://doi.org/10.4103/sjg.SJG_438_17.
Article PubMed PubMed Central Google Scholar
Jalili M, Hekmatdoost A, Vahedi H, Poustchi H, Khademi B, Saadi M, et al. Co-Administration of soy isoflavones and Vitamin D in management of irritable bowel disease. PLoS ONE. 2016;11:e0158545. doi:https://doi.org/10.1371/journal.pone.0158545.
CAS Article PubMed PubMed Central Google Scholar
Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane, 2022. Available from www.training.cochrane.org/handbook.
Ford AC, Sperber AD, Corsetti M, Camilleri M. Irritable bowel syndrome. Lancet. 2020;396:1675–88. doi:https://doi.org/10.1016/S0140-6736(20)31548-8.
CAS Article PubMed Google Scholar
Black CJ, Burr NE, Camilleri M, Earnest DL, Quigley EM, Moayyedi P, et al. Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta-analysis. Gut. 2020;69:74–82. doi:https://doi.org/10.1136/gutjnl-2018-318160.
CAS Article PubMed Google Scholar
Black CJ, Thakur ER, Houghton LA, Quigley EMM, Moayyedi P, Ford AC. Efficacy of psychological therapies for irritable bowel syndrome: systematic review and network meta-analysis. Gut. 2020;69:1441–51. doi:https://doi.org/10.1136/gutjnl-2020-321191.
Tennis P, Andrews E, Hickman P, Miller D, Hollis K, Cook S. The relationship between dosing of alosetron and discontinuation patterns reported by patients participating in a follow-up programme. Aliment Pharmacol Ther. 2007;25:317–22. doi:https://doi.org/10.1111/j.1365-2036.2006.03198.x.
CAS Article PubMed Google Scholar
Cann PA, Read NW, Holdsworth CD, Barends D. Role of loperamide and placebo in management of irritable bowel syndrome (IBS). Dig Dis Sci. 1984;29:239–47. doi:https://doi.org/10.1007/BF01296258.
CAS Article PubMed Google Scholar
Ford AC, Moayyedi P, Lacy BE, Lembo AJ, Saito YA, Schiller LR, et al. American College of Gastroenterology monograph on the management of irritable bowel syndrome and chronic idiopathic constipation. Am J Gastroenterol. 2014;109 Suppl 1. doi:https://doi.org/10.1038/ajg.2014.187.
Bijkerk CJ, de Wit NJ, Muris JWM, Whorwell PJ, Knottnerus JA, Hoes AW. Soluble or insoluble fibre in irritable bowel syndrome in primary care? Randomised placebo controlled trial. BMJ. 2009;339:b3154. doi:https://doi.org/10.1136/bmj.b3154.
CAS Article PubMed PubMed Central Google Scholar
Ford AC, Talley NJ, Spiegel BMR, Foxx-Orenstein AE, Schiller L, Quigley EMM, et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ. 2008;337:a2313. doi:https://doi.org/10.1136/bmj.a2313.
Article PubMed PubMed Central Google Scholar
Engsbro AL, Simren M, Bytzer P. Short-term stability of subtypes in the irritable bowel syndrome: prospective evaluation using the Rome III classification. Aliment Pharmacol Ther. 2012;35:350–9. doi:https://doi.org/10.1111/j.1365-2036.2011.04948.x.
CAS Article PubMed Google Scholar
Drossman DA, Morris CB, Hu Y, Toner BB, Diamant N, Leserman J, et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology. 2005;128:580–9. doi:https://doi.org/10.1053/j.gastro.2004.12.006.
Lacy BE, Patel NK. Rome Criteria and a Diagnostic Approach to Irritable Bowel Syndrome. J Clin Med. 2017;6:99. doi:https://doi.org/10.3390/jcm6110099.
Article PubMed Central Google Scholar
Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Müller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut. 1999;45 Suppl 2:II43-II47. doi: https://doi.org/10.1136/gut.45.2008.ii43.
Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006;130:1480–91. doi:https://doi.org/10.1053/j.gastro.2005.11.061.
Wu C, Qiu S, Zhu X, Li
留言 (0)